Clinical Applications of Extracellular Vesicles in the Diagnosis and Treatment of Traumatic Brain Injury
- 1 October 2020
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Neurotrauma
- Vol. 37 (19), 2045-2056
- https://doi.org/10.1089/neu.2020.6990
Abstract
Extracellular vesicles (EVs) have emerged as key mediators of cell-cell communication during homeostasis and in pathology. Central nervous system (CNS)-derived EVs contain cell type-specific surface markers and intralumenal protein, RNA, DNA, and metabolite cargo that can be used to assess the biochemical and molecular state of neurons and glia during neurological injury and disease. The development of EV isolation strategies coupled with analysis of multi-plexed biomarker and clinical data have the potential to improve our ability to classify and treat traumatic brain injury (TBI) and resulting sequelae. Additionally, their ability to cross the blood-brain barrier (BBB) has implications for both EV-based diagnostic strategies and for potential EV-based therapeutics. In the present review, we discuss encouraging data for EV-based diagnostic, prognostic, and therapeutic strategies in the context of TBI monitoring and management.This publication has 143 references indexed in Scilit:
- Increased Risk of Dementia in Patients with Mild Traumatic Brain Injury: A Nationwide Cohort StudyPLOS ONE, 2013
- Long-term effects of mild traumatic brain injury on cognitive performanceFrontiers in Human Neuroscience, 2013
- Extracellular vesicles as mediators of neuron-glia communicationFrontiers in Cellular Neuroscience, 2013
- The pathophysiology of traumatic brain injury at a glanceDisease Models & Mechanisms, 2013
- High School Football and Risk of Neurodegeneration: A Community-Based StudyMayo Clinic Proceedings, 2012
- Blood–Brain Barrier Pathophysiology in Traumatic Brain InjuryTranslational Stroke Research, 2011
- Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head InjuryJournal of Neuropathology and Experimental Neurology, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature, 2008
- Classification of Traumatic Brain Injury for Targeted TherapiesJournal of Neurotrauma, 2008
- Intravenous Administration of Marrow Stromal Cells (MSCs) Increases the Expression of Growth Factors in Rat Brain after Traumatic Brain InjuryJournal of Neurotrauma, 2004